Actio Biosciences

San Diego, United States

Actio Biosciences is a research center that develops drugs for rare diseases.

$66.0M raised

Jun 2025

Series B

Bioinformatics Biotechnology Genetics

Top Investors

Deerfield ManagementCanaan PartnersEcoR1 CapitalDroia VenturesRegeneron Ventures

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Actio Biosciences

How much funding has Actio Biosciences raised?

Actio Biosciences has raised $66.0M in total funding. The most recent round was Series B. The last funding was announced in June 2025.

Who are Actio Biosciences's investors?

Actio Biosciences's investors include Deerfield Management, Canaan Partners, EcoR1 Capital, Droia Ventures, Regeneron Ventures.

Where is Actio Biosciences headquartered?

Actio Biosciences is headquartered in San Diego, United States.

What does Actio Biosciences do?

Actio Biosciences is a research center that develops drugs for rare diseases.

What stage is Actio Biosciences at?

Actio Biosciences is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 18, 2025.

MLA

"Actio Biosciences — Funding & Investors." VCBacked, June 18, 2025, https://www.vcbacked.co/company/actio-biosciences. Accessed June 18, 2026.

APA

VCBacked. (2025). Actio Biosciences — Funding & Investors. Retrieved June 18, 2026, from https://www.vcbacked.co/company/actio-biosciences

Wikipedia (cite web)

{{cite web |title=Actio Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/actio-biosciences |website=VCBacked |access-date=June 18, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 18, 2025.

Similar Companies in Bioinformatics